术中5-氨基乙酰丙酸荧光引导切除高级别胶质瘤可获得更大切除范围并改善结局:一项系统综述
该系统综述按PRISMA指南检索PubMed与SCOPUS(截至2020年7月16日),最终纳入45项研究,评估5-ALA引导手术治疗高级别胶质瘤对生存与切除范围的影响。作者认为5-ALA的使用与更大的切除范围、更长的总生存和无进展生存相关;术后神经功能缺损方面的结果不一致、尚无定论。
要点
- 5-ALA的使用与高级别胶质瘤手术更大切除范围及更长OS、PFS相关。
- 直接比较5-ALA与白光的13项研究中,5-ALA使88.4%的研究人群PFS更优、67.5%的研究人群OS更优。
- 术后神经功能缺损比较结果不一致,5-ALA为有用手术辅助手段,需以保障患者安全为前提。
核心结论
- 作者认为5-ALA的使用与高级别胶质瘤手术更大切除范围、更长OS和PFS相关。
- 比较5-ALA组与白光组时,术后神经功能缺损发生率结果不一致、尚无定论。
- 作者认为在保障患者安全的前提下,5-ALA是高级别胶质瘤切除的有用手术辅助手段。
研究设计与样本
- 按PRISMA指南进行的系统综述,检索PubMed与SCOPUS两个数据库,检索于2020年7月完成,最终检索日期为2020年7月16日。
- 检索关键词为5-ALA、高级别胶质瘤、5-氨基乙酰丙酸与切除的不同组合,纳入病例报告及回顾性、前瞻性和随机临床试验,系统综述与Meta分析被排除。
- 共筛选3756项已发表研究,其中536项进一步评估,最终45项纳入系统综述;筛选的出版物无日期限制。
主要发现
- 观察到5-ALA组总生存和无进展生存较白光组增加,完全切除者总生存和无进展生存较不完全切除者增加。
- 直接比较5-ALA与白光的研究共13项,占纳入45项研究的28.9%。
- 上述13项研究中,5-ALA分别在88.4%和67.5%的患者中带来更好的无进展生存和总生存。
- 分析报告5-ALA与白光术后神经功能结局的研究时,42.2%的研究对象显示5-ALA与更少术后神经功能缺损相关,34.5%显示5-ALA与不用5-ALA之间无差异,23.3%的研究显示5-ALA引导手术导致更多术后神经功能缺损。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: High-grade gliomas (HGG) are the most aggressive and common malignant brain tumors in adults. They have a dismally fatal prognosis. Even if gross total resection of the enhancing tumor is achieved, inevitably, invading tumor cells that are indistinguishable to the un-aided eye are left behind, which eventually leads to tumor recurrence. 5-aminolevulinic acid (5-ALA) is an increasingly utilized intraoperative fluorescent imaging agent for patients with HGG. It enhances visualization of HGG tissue. Despite early promising randomized clinical trial data suggesting a survival benefit for 5-ALA-guided surgery, the growing body of literature must be analyzed to confirm efficacy on patient outcomes. OBJECTIVE: To perform a systematic review of the literature to evaluate whether there is a beneficial effect upon survival and extent of resection due to the utilization of 5-ALA in HGG surgery. EVIDENCE REVIEW: Literature regarding 5-ALA usage in HGG surgery was reviewed according to the PRISMA guidelines. Two databases, PubMed and SCOPUS, were searched for assorted combinations of the keywords "5-ALA," "high-grade glioma," "5-aminolevulinic acid," and "resection" in July 2020 for case reports and retrospective, prospective, and randomized clinical trials assessing and analyzing 5-ALA intraoperative use in patients with HGG. Entailed studies on PubMed and SCOPUS were found for screening using a snowball search technique upon the initially searched papers. Systematic reviews and meta-analyses were excluded from our PRISMA table. FINDINGS: 3756 previously published studies were screened, 536 of which were further evaluated, and ultimately 45 were included in our systematic review. There were no date restrictions on the screened publications. Our literature search was finalized on July 16, 2020. We found an observed increase in the overall survival (OS) and progression-free survival (PFS) of the 5-ALA group compared to the white light group, as well as an observed increase in the OS and PFS of complete resections compared to incomplete resections. Of the studies that directly compared the use of 5-ALA to white light (13 of the total analyzed 45, or 28.9%), 5-ALA lead to a better PFS and OS in 88.4 and 67.5% of patients, respectively. When the studies that reported postoperative neurologic outcomes of surgeries using 5-ALA vs. white light were analyzed, 42.2% of subjects demonstrated 5-ALA use was associated with less post-op neurological deficits, whereas 34.5% demonstrated no difference between 5-ALA and without. 23.3% of studies showed that intraoperative 5-ALA guided surgeries lead to more post-op neurological deficits. CONCLUSIONS AND RELEVANCE: Utilization of 5-ALA was found to be associated with a greater extent of resection in HGG surgeries, as well as longer OS and PFS. Postop neurologic deficit rates were mixed and inconclusive when comparing 5-ALA groups to white light groups. 5-ALA is a useful surgical adjunct for resection of HGG when patient safety is preserved.
引用
- Eatz TA, Eichberg DG, Lu VM, et al. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review. J Neurooncol. 2022. PMID: 34989964. doi:10.1007/s11060-021-03901-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。